Our GMP plant in Jena provides complete service for the development and manufacture of biopharmaceuticals. Production is based on microbial systems and uses the highly effective DENSETEC^® high-cell-density method or our proprietary ESETEC^® E. coli secretion technology. Based on these technologies, we produce biopharmaceuticals for applications ranging from clinical test samples to commercial market supply. We use our extensive experience to expertly guide you through the validation of your process.

Wacker Biotech GmbH holds certificates from the relevant authorities for its GMP-compliant production of recombinant proteins, and follows the ICH Q7A guidelines for GMP-compliant production of active pharmaceutical ingredients (APIs). Our quality systems are continuously assessed by a combination of internal, customer and official audits.

High quality standards are our maxim. With years of experience in process technology and GMP, our experts are highly committed to transitioning your product from development through to commercial success.